Pharmacokinetics of Sparfloxacin in the Serum and Vitreous Humor of Rabbits: Physicochemical Properties That Regulate Penetration of Quinolone Antimicrobials

ABSTRACT We have used a recently described animal model to characterize the ocular pharmacokinetics of sparfloxacin in vitreous humor of uninfected albino rabbits following systemic administration and direct intraocular injection. The relationships of lipophilicity, protein binding, and molecular weight to the penetration and elimination of sparfloxacin were compared to those of ciprofloxacin, fleroxacin, and ofloxacin. To determine whether elimination was active, elimination rates following direct injection with and without probenecid or heat-killed bacteria were compared. Sparfloxacin concentrations were measured in the serum and vitreous humor by a biological assay. Protein binding and lipophilicity were determined, respectively, by ultrafiltration and oil-water partitioning. Pharmacokinetic parameters were characterized with RSTRIP, an iterative, nonlinear, weighted, least-squares-regression program. The relationship between each independent variable and mean quinolone concentration or elimination rate in the vitreous humor was determined by multiple linear regression. The mean concentration of sparfloxacin in the vitreous humor was 59.4% ± 12.2% of that in serum. Penetration of sparfloxacin, ciprofloxacin, fleroxacin, and ofloxacin into, and elimination from, the vitreous humor correlated with lipophilicity (r2 > 0.999). The linear-regression equation describing this relationship was not improved by including the inverse of the square root of the molecular weight and/or the degree of protein binding. Elimination rates for each quinolone were decreased by the intraocular administration of probenecid. Heat-killedStaphylococcus epidermidis decreased the rate of elimination of fleroxacin. Penetration of sparfloxacin into the noninflamed vitreous humor was greater than that of any quinolone previously examined. There was an excellent correlation between lipophilicity and vitreous entry or elimination for sparfloxacin as well as ciprofloxacin, fleroxacin, and ofloxacin. There are two modes of quinolone translocation into and out of the vitreous humor: diffusion into the eye and both diffusion and carrier-mediated elimination out of the vitreous humor.

[1]  G. Drusano,et al.  Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. , 1996, Experimental eye research.

[2]  F. Sörgel,et al.  Effect of probenecid on the distribution and elimination of ciprofloxacin in humans , 1995, Clinical pharmacology and therapeutics.

[3]  G. Drusano,et al.  Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program , 1995, Antimicrobial agents and chemotherapy.

[4]  G. Drusano,et al.  Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits , 1995, Antimicrobial agents and chemotherapy.

[5]  F. Sörgel,et al.  Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges , 1994, Journal of the Neurological Sciences.

[6]  A. Eller,et al.  The role of ciprofloxacin in endophthalmitis therapy. , 1993, American journal of ophthalmology.

[7]  T. Meredith,et al.  Effects of inflammation and surgery on amikacin levels in the vitreous cavity. , 1993, American journal of ophthalmology.

[8]  M. Sebag,et al.  The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. , 1993, American journal of ophthalmology.

[9]  J. Pocidalo,et al.  Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis , 1993, Antimicrobial Agents and Chemotherapy.

[10]  L. Gutmann,et al.  Sparfloxacin and other new fluoroquinolones. , 1992, The Journal of antimicrobial chemotherapy.

[11]  M. Cooper,et al.  Pharmacokinetics and inflammatory fluid penetration of sparfloxacin , 1992, Antimicrobial Agents and Chemotherapy.

[12]  Y. Iwamoto,et al.  Effects of fenbufen on teh pharmacokinetics of sparfloxacinin rats , 1992 .

[13]  H. Lode,et al.  Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. , 1992, Journal of chromatography.

[14]  J. Pemán,et al.  In vitro activity of sparfloxacin compared with those of five other quinolones , 1992, Antimicrobial Agents and Chemotherapy.

[15]  A. Madu,et al.  Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits , 1992, Antimicrobial Agents and Chemotherapy.

[16]  M. Motyl,et al.  Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits , 1991, Antimicrobial Agents and Chemotherapy.

[17]  J. Sorenson,et al.  Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis , 1991, Antimicrobial Agents and Chemotherapy.

[18]  K. Inui,et al.  Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes. , 1990, The Journal of pharmacology and experimental therapeutics.

[19]  L. Wilson,et al.  Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery. , 1990, Archives of ophthalmology.

[20]  L. Wilson,et al.  Cefazolin levels after intravitreal injection. Effects of inflammation and surgery. , 1990, Investigative ophthalmology & visual science.

[21]  S. Hori,et al.  Renal handling of fleroxacin in rabbits, dogs, and humans , 1990, Antimicrobial Agents and Chemotherapy.

[22]  Trefor Owen Morgan Efficacy of cilazapril compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Multicentre Study Group. , 1989, The American journal of medicine.

[23]  M. Barza Antibacterial agents in the treatment of ocular infections. , 1989, Infectious disease clinics of North America.

[24]  N. Georgopapadakou,et al.  Routes of quinolone permeation in Escherichia coli , 1988, Antimicrobial Agents and Chemotherapy.

[25]  J. Pickard Physiology and Pathophysiology of the Cerebrospinal Fluid , 1988 .

[26]  P. Lehoang,et al.  Pefloxacine et infections oculaires graves. , 1987 .

[27]  R. Wise Methods for Evaluating the Penetration of β-Lactam Antibiotics into Tissues , 1986 .

[28]  W. Culbertson,et al.  Pseudophakic endophthalmitis. Diagnosis and management. , 1986, Ophthalmology.

[29]  S. Mitsuhashi,et al.  Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli , 1986, Antimicrobial Agents and Chemotherapy.

[30]  J. Baum,et al.  Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys. , 1983, Investigative ophthalmology & visual science.

[31]  H. Flynn,et al.  Results in the treatment of postoperative endophthalmitis. , 1983, Ophthalmology.

[32]  W H Oldendorf,et al.  Comparison of lipid-mediated blood-brain-barrier penetrability in neonates and adults. , 1982, The American journal of physiology.

[33]  C. Puliafito,et al.  Infectious Endophthalmitis: Review of 36 Cases , 1982 .

[34]  J. Baum,et al.  The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. , 1982, Investigative ophthalmology & visual science.

[35]  A. Finkelstein,et al.  The nonelectrolyte permeability of planar lipid bilayer membranes , 1980, The Journal of general physiology.

[36]  R. Bellhorn,et al.  Anterior segment permeability to fluorescein-labeled dextrans in the rat. , 1978, Investigative ophthalmology & visual science.

[37]  M. Barza,et al.  Relation Between Lipophilicity and Pharmacological Behavior of Minocycline, Doxycycline, Tetracycline, and Oxytetracycline in Dogs , 1975, Antimicrobial Agents and Chemotherapy.

[38]  H. Akaike A new look at the statistical model identification , 1974 .

[39]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[40]  D. Maurice,et al.  The active transport of fluorescein by the retinal vessels and the retina , 1967, The Journal of physiology.

[41]  A. Churchill The Physiology of the Eye , 1949, The British journal of ophthalmology.

[42]  A. Eller,et al.  Empiric treatment of endophthalmitis. Are aminoglycosides necessary? , 1994, Archives of ophthalmology.

[43]  D. Frazer,et al.  Infective endophthalmitis following vitreoretinal surgery , 1993, Eye.

[44]  J. Baum,et al.  Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits. , 1993, Archives of ophthalmology.

[45]  T. Yamaguchi,et al.  Effect of fenbufen on the pharmacokinetics of sparfloxacin in rats. , 1992, The Journal of antimicrobial chemotherapy.

[46]  C. Nightingale,et al.  Metabolism and the fluoroquinolones. , 1989, The American journal of medicine.

[47]  H. Fukuchi,et al.  Ocular pharmacokinetics of latamoxef and cefaclor in rabbits. Penetration into aqueous humor. , 1988, Journal of pharmacobio-dynamics.

[48]  P. le Hoang,et al.  [Pefloxacine and severe eye infections]. , 1987, Bulletin des societes d'ophtalmologie de France.

[49]  P. Pavan,et al.  Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. , 1987, Ophthalmology.

[50]  R. Wise Methods for evaluating the penetration of beta-lactam antibiotics into tissues. , 1986, Reviews of infectious diseases.

[51]  G. Cuchural,et al.  General principles of antibiotic tissue penetration. , 1985, The Journal of antimicrobial chemotherapy.

[52]  L. Bito,et al.  Transport Functions of the Blood-Retinal Barrier System and the Micro-Environment of the Retina , 1980 .

[53]  J. Swarbrick Drugs and the pharmaceutical sciences , 1975 .

[54]  Milo Gibaldi,et al.  Drugs and the pharmaceutical sciences , 1975 .

[55]  J. Goldman,et al.  The intraocular penetration of chloramphenicol succinate in rabbits. , 1973, Annals of ophthalmology.

[56]  P. Sorensen The penetration of quinine, salicylic acid, PAS, salicyluric acid, barbital and lithium across the vitreous barrier of the rabbit eye. , 1971, Acta pharmacologica et toxicologica.

[57]  H. Knothe,et al.  [Passage of various tetracyclines into human aqueous humor in dependence on their protein binding in the blood serum]. , 1969, Bericht uber die Zusammenkunft. Deutsche Ophthalmologische Gesellschaft.

[58]  Records Re The penicillins in ophthalmology. , 1969 .

[59]  R. Records The penicillins in ophthalmology. , 1969, Survey of ophthalmology.

[60]  N. V. van Haeringen,et al.  Urea and the vitreous barrier of the eye. , 1968, Experimental eye research.